These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34348956)

  • 1. Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated
    Okeah BO; Morrison V; Huws JC
    BMJ Open; 2021 Aug; 11(8):e051983. PubMed ID: 34348956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.
    Hu Y; Yang Y; Feng Y; Fang Q; Wang C; Zhao F; McNally A; Zong Z
    PLoS Med; 2023 Jun; 20(6):e1004233. PubMed ID: 37339120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Further understanding of infection of carbapenems-resistant
    Xiang J; Huan JN
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):790-795. PubMed ID: 30481920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.
    Zhu WM; Yuan Z; Zhou HY
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):23. PubMed ID: 32005246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Huang PH; Chen WY; Chou SH; Wang FD; Lin YT
    Microbiol Spectr; 2022 Jun; 10(3):e0038122. PubMed ID: 35652641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.
    Forde C; Stierman B; Ramon-Pardo P; Dos Santos T; Singh N
    PLoS One; 2017; 12(5):e0176779. PubMed ID: 28542162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis.
    Karampatakis T; Tsergouli K; Lowrie K
    Microb Pathog; 2023 Jun; 179():106090. PubMed ID: 37004964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions.
    Richardson M; Erman A; Daneman N; Miller FA; Sander B
    J Hosp Infect; 2022 Mar; 121():22-31. PubMed ID: 34813872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
    Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
    J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
    Azzini AM; Be G; Naso L; Lambertenghi L; Salerno ND; Coledan I; Bazaj A; Mirandola M; Miotti J; Mazzaferri F; Accordini S; Lo Cascio G; Tacconelli E
    Front Cell Infect Microbiol; 2023; 13():1155320. PubMed ID: 37377644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.
    Liu P; Li X; Luo M; Xu X; Su K; Chen S; Qing Y; Li Y; Qiu J
    Microb Drug Resist; 2018 Mar; 24(2):190-198. PubMed ID: 28749714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program.
    Faraone A; Poggi A; Cappugi C; Tofani L; Riccobono E; Giani T; Fortini A
    Eur J Intern Med; 2020 Aug; 78():50-57. PubMed ID: 32303455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
    Han JH; Goldstein EJ; Wise J; Bilker WB; Tolomeo P; Lautenbach E
    Clin Infect Dis; 2017 Apr; 64(7):839-844. PubMed ID: 28013258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persuasive antimicrobial stewardship intervention in the context of a KPC outbreak: a controlled interrupted time series analysis.
    Rocha-Pereira N; Figueiredo Dias P; Correia S; Shahriari S; Neves J; Teixeira J; Paiva JA; Lima Alves C; Azevedo A
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):55. PubMed ID: 32317012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.